Loading data
QNRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 9.8 m USD | 3.6 m USD | 3.31 m USD | 2.67 m USD | 1.56 m USD |
| Selling, general and administrative expense | 6.49 m USD | 5.93 m USD | 6.07 m USD | 6.58 m USD | 4.5 m USD |
| Profit before tax | -15.8 m USD | -8.96 m USD | — | — | — |
| Net income (reported basis) | -15.8 m USD | -9 m USD | -8.7 m USD | -9.4 m USD | -21.46 m USD |
| Net income attributable to common shareholders | — | — | -8.69 m USD | -9.45 m USD | -21.46 m USD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.